COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, by Roche Molecular Diagnostics The FDA has approved the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, a dual-PCR target HIV-1 viral load test from Roche ...
INDIANAPOLIS, Oct. 3, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company's proprietary dual-target ...
Premier Inc. gave its 1,700 hospital members access in August to the Roche COBAS® Ampliprep/COBAS® TaqMan® HIV-1 assay -- the only real-time PCR test for HIV offered to its members. Premier added the ...
COBAS TaqMan 48 Analyzer (for automated amplification and detection) by Roche Roche announced that the FDA has approved COBAS TaqMan HIV-1 Test v2.0, a new HIV viral load test that targets two highly ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company's proprietary dual-target approach. The COBAS TaqMan HIV-1 Test v2.0 for ...
One-third of Roche Diagnostics' molecular customer base has already purchased or ordered the COBAS AmpliPrep /COBAS TaqMan HIV-1 assay, just eight weeks after the assay received approval from the Food ...
PLEASANTON, Calif., Oct. 25 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food & Drug Administration (FDA) has approved the real-time PCR COBAS® TaqMan® HCV Test, v2 ...
September 24, 2010 — The US Food and Drug Administration (FDA) has approved a fully automated second-generation assay (COBAS AmpliPrep/COBAS TaqMan HBV Test v2.0; Roche Molecular Diagnostics) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results